Summit Therapeutics Inc
NASDAQ:SMMT

Watchlist Manager
Summit Therapeutics Inc Logo
Summit Therapeutics Inc
NASDAQ:SMMT
Watchlist
Price: 17.82 USD 4.58% Market Closed
Market Cap: 13.3B USD

Wall Street
Price Targets

SMMT Price Targets Summary
Summit Therapeutics Inc

Wall Street analysts forecast SMMT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SMMT is 33.08 USD with a low forecast of 12.12 USD and a high forecast of 44.1 USD.

Lowest
Price Target
12.12 USD
32% Downside
Average
Price Target
33.08 USD
86% Upside
Highest
Price Target
44.1 USD
147% Upside
Summit Therapeutics Inc Competitors:
Price Targets
KRYS
Krystal Biotech Inc
6% Downside
2162
KeyMed Biosciences Inc
53% Upside
BCRX
BioCryst Pharmaceuticals Inc
187% Upside
PHIL
Philogen SpA
14% Upside
PGEN
Precigen Inc
101% Upside
BAVA
Bavarian Nordic A/S
35% Upside
300896
Imeik Technology Development Co Ltd
37% Upside
NRIX
Nurix Therapeutics Inc
54% Upside

Revenue
Forecast

Revenue Estimate
Summit Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Summit Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Summit Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SMMT's stock price target?
Price Target
33.08 USD

According to Wall Street analysts, the average 1-year price target for SMMT is 33.08 USD with a low forecast of 12.12 USD and a high forecast of 44.1 USD.

Back to Top